Transplantation
Author:
Keywords:
Science & Technology, Life Sciences & Biomedicine, Immunology, Surgery, Transplantation, RENAL-CELL CARCINOMA, RAPAMYCIN INHIBITORS, IMMUNOSUPPRESSION, RECURRENCE, SURVIVAL, TARGET, CANCER, METAANALYSIS, PROGRESSION, EVEROLIMUS, Adult, Age Factors, Aged, Australia, Canada, Carcinoma, Hepatocellular, Disease Progression, Disease-Free Survival, Drug Therapy, Combination, Europe, Female, Humans, Immunosuppressive Agents, Intention to Treat Analysis, Kaplan-Meier Estimate, Liver Neoplasms, Liver Transplantation, Male, Middle Aged, Neoplasm Recurrence, Local, Prospective Studies, Risk Assessment, Risk Factors, Sirolimus, TOR Serine-Threonine Kinases, Time Factors, Treatment Outcome, Young Adult, 11 Medical and Health Sciences, 3202 Clinical sciences, 3204 Immunology
Abstract:
We investigated whether sirolimus-based immunosuppression improves outcomes in liver transplantation (LTx) candidates with hepatocellular carcinoma (HCC).